{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T13:41:38Z","timestamp":1745156498012},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,14]]},"DOI":"10.7759\/cureus.54214","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:10:47Z","timestamp":1707973847000},"source":"Crossref","is-referenced-by-count":1,"title":["Purpuric Type Drug Eruption Caused by Azithromycin: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Natsuko","family":"Saito-Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/nano.2007.2.1.9","article-title":"Single-dose azithromycin microsphere formulation: a novel delivery system for antibiotics","volume":"2","author":"Amrol D","year":"2007","unstructured":"Amrol D. Single-dose azithromycin microsphere formulation: a novel delivery system for antibiotics. Int J Nanomedicine. 2007, 2:9-12. 10.2147\/nano.2007.2.1.9","journal-title":"Int J Nanomedicine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3280555072","article-title":"How long should we treat community-acquired pneumonia?","volume":"20","author":"Scalera NM","year":"2007","unstructured":"Scalera NM, File TM Jr. How long should we treat community-acquired pneumonia?. Curr Opin Infect Dis. 2007, 20:177-81. 10.1097\/QCO.0b013e3280555072","journal-title":"Curr Opin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/BF01975833","article-title":"Spectrum of activity of azithromycin","volume":"10","author":"Williams JD","year":"1991","unstructured":"Williams JD. Spectrum of activity of azithromycin. Eur J Clin Microbiol Infect Dis. 1991, 10:813-20. 10.1007\/BF01975833","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90395-e","article-title":"Clinical microbiology of azithromycin","volume":"91","author":"Neu HC","year":"1991","unstructured":"Neu HC. Clinical microbiology of azithromycin. Am J Med. 1991, 91:A3-12S. 10.1016\/0002-9343(91)90395-e","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116529","article-title":"The comparative analysis of gastrointestinal toxicity of azithromycin and 3'-decladinosyl azithromycin on zebrafish larvae","volume":"469","author":"Zhang MQ","year":"2023","unstructured":"Zhang MQ, Wu GZ, Zhang JP, Hu CQ. The comparative analysis of gastrointestinal toxicity of azithromycin and 3'-decladinosyl azithromycin on zebrafish larvae. Toxicol Appl Pharmacol. 2023, 469:116529. 10.1016\/j.taap.2023.116529","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref6","article-title":"Stevens-Johnson syndrome as an unusual adverse effect of azithromycin","volume":"14","author":"Brkljacic N","year":"2006","unstructured":"Brkljacic N, Gracin S, Prkacin I, Sabljar-Matovinovic M, Mrzljak A, Nemet Z. Stevens-Johnson syndrome as an unusual adverse effect of azithromycin. Acta Dermatovenerol Croat. 2006, 14:40-5.","journal-title":"Acta Dermatovenerol Croat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1398-9995.2003.00336.x","article-title":"Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection","volume":"59","author":"Aihara Y","year":"2004","unstructured":"Aihara Y, Ito S, Kobayashi Y, Aihara M. Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection. Allergy. 2004, 59:118. 10.1046\/j.1398-9995.2003.00336.x","journal-title":"Allergy"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1080\/0036554021000026949","article-title":"Azithromycin-induced rash in infectious mononucleosis","volume":"34","author":"Dakdouki GK","year":"2002","unstructured":"Dakdouki GK, Obeid KH, Kanj SS. Azithromycin-induced rash in infectious mononucleosis. Scand J Infect Dis. 2002, 34:939-41.","journal-title":"Scand J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01558.x","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr virus infection","volume":"28","author":"Bauer KA","year":"2011","unstructured":"Bauer KA, Brimhall AK, Chang TT. Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr virus infection. Pediatr Dermatol. 2011, 28:741-3. 10.1111\/j.1525-1470.2011.01558.x","journal-title":"Pediatr Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-8-332","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report","volume":"8","author":"Sriratanaviriyakul N","year":"2014","unstructured":"Sriratanaviriyakul N, Nguyen LP, Henderson MC, Albertson TE. Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report. J Med Case Rep. 2014, 8:332. 10.1186\/1752-1947-8-332","journal-title":"J Med Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01191.x","article-title":"Toxic pustuloderma associated with azithromycin","volume":"19","author":"Trevisi P","year":"1994","unstructured":"Trevisi P, Patrizi A, Neri I, Farina P. Toxic pustuloderma associated with azithromycin. Clin Exp Dermatol. 1994, 19:280-1. 10.1111\/j.1365-2230.1994.tb01191.x","journal-title":"Clin Exp Dermatol"},{"key":"ref12","article-title":"Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction","volume":"65","author":"Schissel DJ","year":"2000","unstructured":"Schissel DJ, Singer D, David-Bajar K. Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction. Cutis. 2000, 65:163-6.","journal-title":"Cutis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.2.155","article-title":"Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis","volume":"142","author":"Bahrami S","year":"2006","unstructured":"Bahrami S, Malone JC, Webb KG, Callen JP. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol. 2006, 142:155-61. 10.1001\/archderm.142.2.155","journal-title":"Arch Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1989.tb01252.x","article-title":"Drug-induced chronic pigmented purpura","volume":"16","author":"Nishioka K","year":"1989","unstructured":"Nishioka K, Katayama I, Masuzawa M, Yokozeki H, Nishiyama S. Drug-induced chronic pigmented purpura. J Dermatol. 1989, 16:220-2. 10.1111\/j.1346-8138.1989.tb01252.x","journal-title":"J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185054-purpuric-type-drug-eruption-caused-by-azithromycin-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:10:54Z","timestamp":1707973854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185054-purpuric-type-drug-eruption-caused-by-azithromycin-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.54214","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,14]]}}}